Skip to main content
. 2022 Jan 31;49(3):2321–2324. doi: 10.1007/s11033-022-07183-w

Table 1.

Cardiorenal protective effects of empagliflozin

A Reduced oxidative stress
B Enhanced mitochondrial structure and function
C Minimization of coronary microvascular injury
D Decreased inflammation
E Improved contractile performance
F Reduced glomerular and tubular inflammation and injury